Form 4: Director Bakari Sellers Receives cbdMD Equity Grant
Statement of Changes in Beneficial Ownership
Director Bakari Sellers was granted 1,572 restricted stock units as compensation for board service at cbdMD, Inc.
Summary
- Director Bakari Sellers acquired 1,572 restricted stock units (RSUs) of cbdMD, Inc. common stock.
- The transaction occurred on April 14, 2026.
- The RSUs represent a contingent right to receive one share of common stock per unit.
- The grant serves as compensation for the director's services on the Board of Directors.
- Following this transaction, the director's total beneficial ownership is 4,324 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.
Positives
- The equity grant aligns the director's interests with those of shareholders through long-term stock ownership.
Negatives
- None identified.
Risks
- The value of the equity compensation is subject to the market performance of cbdMD common stock.
Future Outlook
The restricted stock units will vest in four equal quarterly installments starting June 30, 2026, and concluding March 31, 2027.
Management Comments
- The grant was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee.
Industry Context
StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice designed to incentivize long-term value creation in the consumer goods and wellness sectors.
Comparison to Industry Standards
- The use of quarterly vesting schedules for director compensation is consistent with standard corporate governance practices for small-cap public companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Issuance of restricted stock units to a director under the 2021 or 2025 Equity Compensation Plan. | 04/14/2026 | Standard compensation practice; no material change to governance structure. |
Stakeholder Impact
- Shareholders: Minimal impact; represents standard director compensation.
Next Steps
- Vesting of restricted stock units on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Date of the equity grant transaction. |
| 04/16/2026 | Date the Form 4 was signed and filed. |
| 06/30/2026 | First quarterly vesting date for the restricted stock units. |
| 03/31/2027 | Final quarterly vesting date for the restricted stock units. |
Keywords
cbdMD, YCBD, Form 4, Insider Trading, Equity Compensation, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.